Seawolf Therapeutics
Seawolf Therapeutics is a biotechnology company that transforms patient outcomes through the use of its LNP-based DNA delivery platform.
$100M Seed ·
Led by Versant Ventures · Source: businesswire.com
Funding history ↓Signals
Website registeredJun 16, 2021 (5 years old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Seed | $100M | businesswire.com |
Timeline
- Website created
Investors
AAlexandria Venture Investments
CCRISPR Therapeutics
EEli Lilly
MMPM BioImpact
NNovartis Venture Fund
PPathway to Cures
SSixty Degree Capital
VVersant Ventureslead investor
Companies like Seawolf Therapeutics
CCity TherapeuticsSeries B+ · Aug 2026
PParcelBioSeed · May 2026
LLaurel$100M Series B+ · Jun 2025
GGranite Bio$30M Series A · Apr 2025
NNewLimit$435M Series B+ · Jun 2026
FFoRx Therapeutics$50M Series A · Dec 2025
Other companies backed by Versant Ventures
NNouscom$135.04M Series B+ · Oct 2026
MMonteris Medical$28M Series B+ · Mar 2026
GGranite Bio$30M Series A · Apr 2025
KKate Therapeutics$51M Series A · Jun 2023
JJnana Therapeutics$107M Series B+ · Nov 2022
TT-Knife$110M Series B+ · Aug 2021
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/seawolf-therapeutics (get a free API key).